PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
4.09%
Some net income increase while MCHP is negative at -4.27%. John Neff would see a short-term edge over the struggling competitor.
12.15%
D&A growth well above MCHP's 1.95%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-1300.00%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
14.86%
SBC growth while MCHP is negative at -1.59%. John Neff would see competitor possibly controlling share issuance more tightly.
-109.18%
Both reduce yoy usage, with MCHP at -348.62%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-320.21%
AR is negative yoy while MCHP is 603.33%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
7.33%
Some inventory rise while MCHP is negative at -59.38%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
72.73%
Lower AP growth vs. MCHP's 566.67%, indicating prompt payments. David Dodd would confirm no lost opportunity in interest-free credit if expansions are underfunded.
-75.90%
Both reduce yoy usage, with MCHP at -146.47%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-517.86%
Negative yoy while MCHP is 448.55%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-17.54%
Both yoy CFO lines are negative, with MCHP at -2.89%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-34.76%
Negative yoy CapEx while MCHP is 9.04%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-50.00%
Negative yoy acquisition while MCHP stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
38.29%
Purchases growth of 38.29% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
51.41%
Liquidation growth of 51.41% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
730.77%
Growth well above MCHP's 14.82%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
173.44%
Investing outflow well above MCHP's 14.82%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-1.75%
Negative yoy issuance while MCHP is 73.77%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-100.68%
We cut yoy buybacks while MCHP is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.